the Horsens Aarhus FemoroAcetabular Impingement Syndrome Training Pilot Study

July 30, 2025 updated by: Jeppe Lange, Horsens Hospital
The aim of the study is to investigate the feasibility of a training intervention in patients with femoroacetabular impingement syndrome (FAIS).

Study Overview

Status

Completed

Detailed Description

The aim of this study is to investigate the feasibility of a 12-weeks (progressive) exercise program in patients with FAIS. Feasibility is evaluated on the recruitment strategy, patient adherence to the exercises and their experiences with and motivation for performing exercises. Furthermore, the investigators wish to investigate the variation of data before and after the exercise program to help estimate a suitable sample size for a future randomized controlled trial.

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Danmark
      • Horsens, Danmark, Denmark, DK-8700
        • Signe Kierkegaard

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients aged 18-50 years old
  2. Diagnosed with FAIS according to the Warwick agreement
  3. Patients having cam morphology should have an alpha angle of > 55 degrees on an anterior-posterior radiograph.
  4. Patients having pincer should have a lateral centre edge angle of >39 degrees on an anterior-posterior radiograph.
  5. Lateral joint space width should be >3 mm.
  6. Body mass index is below 30.
  7. Motivated for participation in a 12 week training program with 8 physical attendances.

Exclusion Criteria:

  1. Received physiotherapist-led treatment in the past 3 months,
  2. Previous hip surgery in included hip or other major hip injury,
  3. Systemic conditions e.g. rheumatoid arthritis, cancer,
  4. Chronical pain syndromes,
  5. Unable to perform testing procedures,
  6. Unable to attend a 12-week treatment program or baseline and follow-up assessments
  7. Contraindications to radiographs (e.g. pregnancy)
  8. Unable to read or understand questionnaires and/or instructions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Physiotherapist-led training
Physiotherapy-led training of patients with FAIS
Patients will undergo a 12-week physiotherapist-led training program consisting of 8 supervised sessions and home-based training in between

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of completed exercise sessions
Time Frame: 0-12 weeks
Number of completed exercise sessions. A high adherence is defined as attendance of > 75% of planned sessions
0-12 weeks
Completion of training program
Time Frame: 0-12 weeks
The training program is considered completed if patients are not dropping out of the study before the end of the 12 weeks. Completion rate will be calculated as % patients who completed the study
0-12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Copenhagen Hip and Groin Outcome Score (HAGOS)
Time Frame: Change from 0-12 weeks
HAGOS is a questionnaire developed for young, active persons experiencing hip and/or groin pain. It consists of 6 subscales: Pain, Symptoms, Activities of Daily Living, Sport, Participation in Sport and Hip-related quality of life. The main subscales used in this study are HAGOS pain and sport.
Change from 0-12 weeks
The International Hip Outcome Tool (iHOT-33)
Time Frame: Change from 0-12 weeks
iHOT-33 is a questionnaire focussing at patients' hip related quality of life in 33 questions. Both a total score and sub scales: "Symptoms and functional limitations", "Sports and recreational activities", "Job related concerns" and "Social, emotional and lifestyle concerns", are extracted from the questionnaire.
Change from 0-12 weeks
The Hip Sports Activity Scale (HSAS)
Time Frame: Change from 0-12 weeks
Current physical activity measured from 0 to 8 points, 0 being no activity and 8 being an athlete
Change from 0-12 weeks
Maximal hip muscle strength
Time Frame: Change from 0-12 weeks
Change (Nm/kg) in maximal hip flexion, extension, abduction and adduction from 0-12 weeks
Change from 0-12 weeks
One-legged hop for distance
Time Frame: 0-12 weeks
Change (cm) i hop distance from 0-12 weeks
0-12 weeks
Y-balance board
Time Frame: 0-12 weeks
Change (cm) in ability to perform on the y balance board from 0-12 weeks
0-12 weeks
Patient Acceptable Symptom State
Time Frame: 0-12 weeks
Patient Acceptable Symptom State (yes/no): Change in number of patients reporting yes vs. no from baseline to 12 weeks
0-12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Signe Kierkegaard, PhD, Regionshospitalet Horsens

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2021

Primary Completion (Actual)

August 1, 2022

Study Completion (Actual)

December 1, 2022

Study Registration Dates

First Submitted

August 12, 2021

First Submitted That Met QC Criteria

August 26, 2021

First Posted (Actual)

September 1, 2021

Study Record Updates

Last Update Posted (Actual)

August 3, 2025

Last Update Submitted That Met QC Criteria

July 30, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 1-16-02-724-18

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Pilot study with few participants.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Femoroacetabular Impingement

Clinical Trials on Physiotherapist-led training

Subscribe